Miprogen Gel

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Miprogen Gel contains progesterone, a natural female sex hormone, formulated as a vaginal gel. Its labelling describes it for restoring menstruation in women whose periods have stopped because of a lack of natural progesterone (not due to menopause), for supporting fertility treatment and the maintenance of pregnancy, and as part of hormone replacement therapy to relieve menopausal symptoms and limit thickening of the endometrium.

Active ingredient
Progesterone
Dosage form
Vaginal gel
Therapeutic class
Progestogen (natural progesterone)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with progesterone and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for restoring menstruation in women whose periods have stopped due to a lack of natural progesterone
  • Described for supporting fertility treatment and the maintenance of pregnancy
  • Described as part of hormone replacement therapy, to relieve menopausal symptoms such as hot flushes, night sweats, vaginal dryness, mood swings, and reduced sex drive
  • Described as helping to limit thickening of the endometrium during hormone replacement therapy
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • For vaginal use only, at the dose and duration set by the doctor; if no specific instructions are given, the label may be followed
  • Applied after cleaning and drying the area, with the hands washed after application
  • Treatment should not be stopped before the prescribed duration is complete, even after pregnancy

Described Side Effects

Commonly described side effects include:

  • Tiredness (fatigue)
  • Headache
  • Joint pain
  • Abnormal menstrual bleeding
  • Musculoskeletal (bone, muscle, or joint) pain
  • Vertigo

These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • The doctor should be told about any current or previous breast cancer, any unusual vaginal bleeding, or any liver disease
  • An updated medical history should be shared with the healthcare team, and any tests arranged during treatment should be cooperated with
  • The gel is described as affecting focus, so tasks needing full attention should be avoided; alcohol should not be consumed
  • Any persistent or severe side effect should be reviewed by a clinician

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains progesterone and is used as a vaginal gel to restore menstruation in women with progesterone deficiency, to support fertility treatment and the maintenance of pregnancy, and as part of hormone replacement therapy. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as for vaginal use only, applied at the dose and duration set by the doctor after cleaning and drying the area, with the hands washed afterwards. Treatment should not be stopped before the prescribed duration is complete.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services